Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2109 of 5804
-
New drug combo aims to tame rare blood cancer and prep for transplant
Disease control OngoingThe main goal of this clinical research study is to learn if Velcade ® (bortezomib) given with rituximab can help to control WM. This drug combination will allow researchers to collect your stem cells in case it is possible to transplant the stem cells as treatment if your WM get…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Brain scans aim to unlock dementia mystery in Parkinson's
Knowledge-focused OngoingThe purpose of this study is to use a brain imaging method called PIB PET to determine dementia subtypes in patients with Parkinson's disease. The ultimate goal of this project is to be able to identify individuals with PD who are at risk of developing dementia, and to distinguis…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Gene test could predict antidepressant success
Knowledge-focused CompletedThe main hypothesis is that the therapeutic response and pharmacological resistance to ADs in depressed patients can be associated with a polymorphism for the BDNF gene. The research of allelic forms associated to lesser efficiency or inefficiency of ADs could add to the body of …
Phase: PHASE4 • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Could a simple score predict dementia in depressed seniors?
Knowledge-focused Recruiting nowThe goal of this observational study is to learn about the ability of a point risk score prediction model, developed using electronic medical record data, to predict the risk of progression from geriatric depression to dementia in older Chinese adults. The main questions it aims …
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Which heart device lead lasts longest in kids? study aims to find out
Disease control TerminatedThis is a randomized, prospective clinical trial comparing 2 different types of implantable cardioverter defibrillator (ICD) leads in children and patients with congenital heart disease. ICD lead survival in this patient group is particularly suboptimal, and lead extraction is te…
Phase: NA • Sponsor: Charles Berul • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
AI reads your Heart's future: new test spots cancer drug danger
Knowledge-focused CompletedThis study investigates the use of AI-enhanced electrocardiogram (ECG) for risk stratification of cancer therapy-related cardiac dysfunction (CTRCD) before the initiation of cancer therapy. The study includes patients treated with anthracyclines, HER2 inhibitors, or immune checkp…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Light may spot cervical cancer before it spreads
Diagnosis Recruiting nowThe objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.
Phase: NA • Sponsor: Duke University • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Proton beam therapy takes aim at rare skull base cancer
Disease control OngoingThe goal of this clinical research study is to learn if proton beam therapy, with or without photon beam radiation therapy, is effective in the treatment of skull base chondrosarcoma. The safety of this treatment will also be studied.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Kidney cancer drugs fail to prevent recurrence after surgery
Disease control CompletedThis randomized phase III trial studies sunitinib malate to see how well it works compared to sorafenib tosylate or placebo in treating patients with kidney cancer that has been removed by surgery. Sunitinib malate and sorafenib tosylate may stop the growth of tumor cells by bloc…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Supercharged t cells take on Hard-to-Treat lymphoma
Disease control OngoingPatients have a type of lymph gland cancer called HD, NHL or lymphoepithelioma (these 3 diseases will be referred to as "Lymphoma"). The lymphoma has come back or has not gone away after treatment. This is a research study using special immune system cells called TGFb-resistant L…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Blood markers could spot sepsis risk early
Knowledge-focused Recruiting nowThe purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Can a nerve pain drug ease chronic pelvic pain?
Symptom relief CompletedThe purpose of this study is to determine whether pregabalin is an effective treatment for Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Phase: PHASE3 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New combo therapy targets tough head and neck cancers
Disease control CompletedThe purpose of this study is to determine the safety and effectiveness of treatment with Tarceva (Erlotinib) and RADPLAT (RADiation and intraarterial cisPLATin) for patients with Head and Neck cancer
Phase: PHASE2 • Sponsor: Southern Illinois University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can a common steroid ease cancer symptoms? new trial investigates
Symptom relief OngoingThe goal of this clinical research study is to learn if dexamethasone can help to control symptoms such as fatigue, pain, nausea, weight loss, loss of appetite, sleep problems, and/or depression in patients with advanced cancer.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New PTH test could Fine-Tune mineral balance in kidney dialysis
Disease control CompletedThis study included 80 patients with end stage renal disease requiring dialysis treatment to evaluate two techniques for the determination of parathyroid hormone (PTH) Objective: To evaluate whether the monitoring of hemodialysis patients by measurement of PTH 1-84 Complete (CAP…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Virus injection targets liver tumors in early trial
Disease control CompletedThe primary purpose of this study is to determine the maximum tolerable dose (MTD) and/or the maximum feasible dose (MFD), as well as to evaluate the safety of JX-594 (Pexa-Vec) injected within hepatic carcinoma tumors.
Phase: PHASE1 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New Two-Drug cocktail shows promise for HIV suppression
Disease control CompletedThe purpose of this study is to evaluate virological efficacy and safety of two double protease inhibitor regimens: atazanavir/fosamprenavir/ritonavir 300 mg once daily/ 700/100 mg twice daily, versus atazanavir/saquinavir/ritonavir 300/1500/100 mg once daily in protease inhibito…
Phase: PHASE2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Drug dasatinib tested for rare blood cancers
Disease control CompletedThe goal of this clinical research study is to learn if dasatinib can help to control myeloproliferative disorders. The safety and tolerability of dasatinib will also be studied.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a blood pressure drug help fight melanoma?
Disease control CompletedThe study is designed as a multicenter, double blind, parallel-group, placebo-controlled, randomized, event driven Phase II study of DTIC with or without bosentan as first-line treatment in patients with stage IV melanoma.
Phase: PHASE2 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a safer scan replace standard CT for testicular cancer Follow-Up?
Diagnosis OngoingPatients with primary germ cell cancer of the testicles confined to the testis can avoid adjuvant treatment by entering a surveillance protocol. In the surveillance protocol, patients are followed for up to ten years with serial computed tomography scans to detect recurrence. Mul…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC